PubRank
Search
About
N Horiike
Author PubWeight™ 42.31
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan.
Hepatology
2001
2.62
2
Induction of cytokine production and proliferation of memory lymphocytes by murine liver dendritic cell progenitors: role of these progenitors as immunogenic resident antigen-presenting cells in the liver.
J Hepatol
2001
1.67
3
Low stimulatory capacity of lymphoid dendritic cells expressing hepatitis C virus genes.
Biochem Biophys Res Commun
1998
1.31
4
Mechanism of action of vaccine therapy in murine hepatitis B virus carriers: vaccine-induced activation of antigen presenting dendritic cells.
J Hepatol
1999
1.27
5
Dendritic cells with immature phenotype and defective function in the peripheral blood from patients with hepatocellular carcinoma.
J Hepatol
1999
1.16
6
Noninvasive diagnosis of the degree of hepatic fibrosis using ultrasonography in patients with chronic liver disease due to hepatitis C virus.
Eur J Clin Invest
2001
1.15
7
Decreased interferon-alpha production and impaired T helper 1 polarization by dendritic cells from patients with chronic hepatitis C.
Clin Exp Immunol
2004
1.06
8
Macrophage migration inhibitory factor activates antigen-presenting dendritic cells and induces inflammatory cytokines in ulcerative colitis.
Clin Exp Immunol
2002
1.05
9
Macrophage migration inhibitory factor in hepatocellular carcinoma and liver cirrhosis; relevance to pathogenesis.
Cancer Lett
2001
1.01
10
Increased serum levels of macrophage migration inhibitory factor in alcoholic liver diseases and their expression in liver tissues.
Clin Biochem
2001
0.98
11
Prognostic importance of antigen-presenting dendritic cells during vaccine therapy in a murine hepatitis B virus carrier.
Immunology
1999
0.97
12
Hepatitis C virus clearance is prominent in women in an endemic area.
J Gastroenterol Hepatol
2000
0.96
13
Mechanism and therapeutic potential of DNA-based immunization against the envelope proteins of hepatitis B virus in normal and transgenic mice.
Immunology
2001
0.95
14
Absence of CD83-positive mature and activated dendritic cells at cancer nodules from patients with hepatocellular carcinoma: relevance to hepatocarcinogenesis.
Cancer Lett
2000
0.95
15
Present status of autoimmune hepatitis in Japan.
Gastroenterol Jpn
1993
0.95
16
Impaired functional capacities of liver dendritic cells from murine hepatitis B virus (HBV) carriers: relevance to low HBV-specific immune responses.
Clin Exp Immunol
2005
0.93
17
Existence of TT virus DNA in extracellular body fluids from normal healthy Japanese subjects.
Intervirology
2000
0.93
18
Dendritic cells and chronic hepatitis virus carriers.
Intervirology
2001
0.92
19
Isolation and functional analysis of circulating dendritic cells from hepatitis C virus (HCV) RNA-positive and HCV RNA-negative patients with chronic hepatitis C: role of antiviral therapy.
Clin Exp Immunol
2004
0.92
20
Placebo-controlled trial of vaccination with hepatitis B virus surface antigen in hepatitis B virus transgenic mice.
J Hepatol
1997
0.91
21
The CD81 expression in liver in hepatocellular carcinoma.
Int J Mol Med
2001
0.88
22
Intrahepatic lymphocyte subpopulations and HLA class I antigen expression by hepatocytes in chronic hepatitis C.
Hepatogastroenterology
1992
0.88
23
X region deletion variants of hepatitis B virus in surface antigen-negative infections and non-A, non-B hepatitis.
J Infect Dis
1995
0.86
24
Mechanisms of alcoholic liver disease: cytokines.
Alcohol Clin Exp Res
2001
0.85
25
Potent synergistic effect of sho-saiko-to, a herbal medicine, during vaccine therapy in a murine model of hepatitis B virus carrier.
Eur J Clin Invest
1999
0.85
26
Peripheral blood T-cell responses to pyruvate dehydrogenase complex in primary biliary cirrhosis: role of antigen-presenting dendritic cells.
Eur J Clin Invest
2001
0.85
27
Antigen-presenting cells at the liver tissue in patients with chronic viral liver diseases: CD83-positive mature dendritic cells at the vicinity of focal and confluent necrosis.
Hepatol Res
2001
0.84
28
Hepatitis B X open reading frame deletion mutants isolated from atypical hepatitis B virus infections.
J Hepatol
1991
0.84
29
Safety and immunogenicity of hepatitis B surface antigen-pulsed dendritic cells in patients with chronic hepatitis B.
J Viral Hepat
2011
0.84
30
Effect of recombinant interleukin 2 on hepatitis B e antigen positive chronic hepatitis.
Gut
1987
0.83
31
Serum levels of soluble CD4 and CD8 in patients with chronic viral hepatitis.
Hepatogastroenterology
1994
0.83
32
Serum IL-8 levels and localization of IL-8 in liver from patients with chronic viral hepatitis.
Hepatogastroenterology
1999
0.83
33
Increased serum levels of macrophage inflammatory protein-3alpha in chronic viral hepatitis: prognostic importance of macrophage inflammatory protein-3alpha during interferon therapy in chronic hepatitis C.
J Viral Hepat
2002
0.82
34
[The efficacy of lidocaine in the status epilepticus (author's transl)].
No To Shinkei
1980
0.82
35
Anti-HCV immunoglobulin M antibody in patients with acute and fulminant hepatitis C.
Gastroenterol Jpn
1993
0.81
36
Precore and X region mutants in hepatitis B virus infections among renal dialysis patients.
J Viral Hepat
1995
0.80
37
Assay of serum interleukin 8 levels in patients with alcoholic hepatitis.
Alcohol Alcohol Suppl
1993
0.80
38
Induction of CINC (interleukin-8) production in rat liver by non-parenchymal cells.
J Gastroenterol Hepatol
1998
0.79
39
[An epidemiological study of hepatitis C virus infection in a local district in Japan].
Rinsho Byori
1991
0.79
40
Proatlantal intersegmental artery with absence of bilateral vertebral arteries. Case report.
J Neurosurg
1981
0.78
41
[A case of hemophagocytic syndrome with severe liver injury manifestating adult Still's disease].
Nihon Rinsho Meneki Gakkai Kaishi
1997
0.78
42
Influence of RNA titre and amino acid changes in the NS5A region of GB virus c/hepatitis G virus on the effectiveness of interferon therapy.
J Gastroenterol Hepatol
2000
0.78
43
Hepatitis B virus replication in dark reddish patchy markings appearing on the hepatic surface.
Gastrointest Endosc
1990
0.78
44
Mechanism of restoration of immune responses of patients with chronic hepatitis B during lamivudine therapy: increased antigen processing and presentation by dendritic cells.
J Viral Hepat
2011
0.77
45
In situ detection of mutated hepatitis B virus in microdissected, formalin-fixed liver tissues from patients with chronic hepatitis B.
J Hepatol
1999
0.77
46
The seroepidemiology of hepatitis A and B in a Japanese town.
Asia Pac J Public Health
1993
0.77
47
Prediction of interferon-alpha-induced thyroid dysfunction in patients with chronic hepatitis C.
J Gastroenterol Hepatol
1996
0.76
48
Dendritic cell-based immunotherapy for hepatocellular carcinoma.
J Gastroenterol
2001
0.75
49
[Genetic and epidemiologic studies on alcoholic liver diseases].
Arukoru Kenkyuto Yakubutsu Ison
1993
0.75
50
Identification of intrahepatic lymphocyte subpopulations in patients with fulminant hepatitis by the immunoenzymatic technique, using monoclonal antibodies.
Hepatogastroenterology
1987
0.75
51
[R-PHA and PHA methods for the detection of HBeAg and anti-HBe].
Rinsho Byori
1984
0.75
52
[Beta 2-microglobulin of peripheral blood mononuclear cells measured by enzyme immunoassay using microplate].
Rinsho Byori
1989
0.75
53
[A cell kinetic study of liver cells in various liver diseases by the detection of DNA polymerase alpha].
Nihon Shokakibyo Gakkai Zasshi
1989
0.75
54
Retreatment with interferon in chronic hepatitis C.
J Hepatol
1994
0.75
55
[Sequential changes in blood concentrations of tegafur and 5-FU during oral administration of fine granules of tegafur in patients with primary liver cancer].
Gan To Kagaku Ryoho
1982
0.75
56
[Studies on the relationship between HLA-class I displays on the hepatocyte membrane and liver injury in patients with chronic hepatitis type B].
Nihon Shokakibyo Gakkai Zasshi
1987
0.75
57
Laparoscopic histopathological analysis of "gentle undulation" findings observed in patients with primary biliary cirrhosis.
Endoscopy
1987
0.75
58
Immunohistochemical localization of metallothionein in hepatocellular carcinoma: preferential expression in non-cancerous cirrhotic nodules.
Oncol Rep
1998
0.75
59
[Virological studies on patients with anti-HBe positive chronic hepatitis showing GPT fluctuation].
Nihon Shokakibyo Gakkai Zasshi
1987
0.75
60
The use of lidocaine in the management of status epilepticus.
Folia Psychiatr Neurol Jpn
1980
0.75
61
Significance of sublobular hepatic necrosis in the progression of chronic hepatitis C.
J Gastroenterol Hepatol
1993
0.75
62
An autopsy case of primary biliary cirrhosis with severe interstitial pneumonia.
Intern Med
2001
0.75
63
Spontaneous development of chronic non-suppurative destructive cholangitis in senescent mice.
Gastroenterol Jpn
1991
0.75
64
Change of hepatitis B virus DNA distribution associated with the progression of chronic hepatitis.
Liver
1988
0.75
65
Mutation of the core region of HBV-DNA and submassive hepatic necrosis in patients with anti-HBe-positive chronic hepatitis B.
J Gastroenterol Hepatol
1992
0.75
66
GB virus C/hepatitis G virus infection in autoimmune liver diseases.
J Gastroenterol
1998
0.75
67
Three patients with autoimmune cholangiopathy treated with prednisolone.
J Gastroenterol
1998
0.75
68
Immunoglobulin G subclasses of antibodies to hepatitis B core antigen in HBs antigen positive liver diseases.
J Gastroenterol Hepatol
1991
0.75
69
[Etiological implication of delta agent to HBsAg-positive liver diseases].
Rinsho Byori
1987
0.75
70
Hyperplastic liver nodules associated with early-stage primary biliary cirrhosis mimicking hepatocellular carcinoma.
Dig Dis Sci
2000
0.75
71
[Detection of minus strand HCV RNA in liver tissue by reverse transcriptase polymerase chain reaction (RT-PCR)].
Rinsho Byori
1993
0.75
72
[A staining method of PIVKA-II by an indirect immunoenzyme technic].
Rinsho Byori
1989
0.75
73
[The detection of anti-HBc by a passive hemagglutination method].
Rinsho Byori
1985
0.75
74
Presence of a translational stop codon in the precore region of HBVDNA in the HBeAg positive stage of chronic hepatitis B.
Gastroenterol Jpn
1990
0.75
75
[Diagnostic value of anti-HBc IgM detection by an enzyme-immunoassay method in various liver diseases (type B)].
Rinsho Byori
1985
0.75
76
Patterns and pathobiology of hepatic necrosis in chronic viral hepatitis.
Gastroenterol Jpn
1993
0.75
77
Intrafamilial transmission of hepatitis C virus in Japan.
Gastroenterol Jpn
1991
0.75
78
[A case of nephrotic syndrome associated with eosinophilic angiolymphoid hyperplasia].
Nihon Naika Gakkai Zasshi
1991
0.75
79
[Detection of Ki-67 in liver biopsy specimens using monoclonal antibody to Mib-1].
Rinsho Byori
1999
0.75